These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12729946)
1. Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain. O'Donnell T; Rotzinger S; Nakashima TT; Hanstock CC; Ulrich M; Silverstone PH Eur Neuropsychopharmacol; 2003 May; 13(3):199-207. PubMed ID: 12729946 [TBL] [Abstract][Full Text] [Related]
2. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. O'Donnell T; Rotzinger S; Nakashima TT; Hanstock CC; Ulrich M; Silverstone PH Brain Res; 2000 Oct; 880(1-2):84-91. PubMed ID: 11032992 [TBL] [Abstract][Full Text] [Related]
3. Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol. McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH Neuroreport; 2007 Oct; 18(15):1595-8. PubMed ID: 17885608 [TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC Int Clin Psychopharmacol; 2003 Mar; 18(2):73-9. PubMed ID: 12598817 [TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549 [TBL] [Abstract][Full Text] [Related]
6. Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation. Bell EC; Willson MC; Wilman AH; Dave S; Asghar SJ; Silverstone PH Hum Psychopharmacol; 2005 Mar; 20(2):87-96. PubMed ID: 15651051 [TBL] [Abstract][Full Text] [Related]
7. Valproate attenuates dextroamphetamine-induced subjective changes more than lithium. Willson MC; Bell EC; Dave S; Asghar SJ; McGrath BM; Silverstone PH Eur Neuropsychopharmacol; 2005 Dec; 15(6):633-9. PubMed ID: 15949922 [TBL] [Abstract][Full Text] [Related]
8. Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS. Silverstone PH; Rotzinger S; Pukhovsky A; Hanstock CC Biol Psychiatry; 1999 Dec; 46(12):1634-41. PubMed ID: 10624544 [TBL] [Abstract][Full Text] [Related]
9. Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients. Silverstone PH; McGrath BM Int Rev Psychiatry; 2009; 21(4):414-23. PubMed ID: 20374155 [TBL] [Abstract][Full Text] [Related]
10. The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates. Dixon JF; Hokin LE Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4757-60. PubMed ID: 9114064 [TBL] [Abstract][Full Text] [Related]
11. Effects of chronic lithium and sodium valproate on concentrations of brain amino acids. O'Donnell T; Rotzinger S; Ulrich M; Hanstock CC; Nakashima TT; Silverstone PH Eur Neuropsychopharmacol; 2003 Aug; 13(4):220-7. PubMed ID: 12888180 [TBL] [Abstract][Full Text] [Related]
12. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? Lenox RH; McNamara RK; Watterson JM; Watson DG J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502 [TBL] [Abstract][Full Text] [Related]